Gainers
- 23andMe Holding ME shares moved upwards by 12.3% to $2.83 during Wednesday's after-market session. Trading volume for this security closed at 189.4K, accounting for 7.2% of its average full-day volume over the last 100 days. The market value of their outstanding shares is at $1.2 billion. The company's, Q3 earnings came out today.
- Revelation Biosciences REVB stock moved upwards by 11.94% to $6.0. The market value of their outstanding shares is at $4.0 million.
- Decibel Therapeutics DBTX stock increased by 7.88% to $4.65. The company's market cap stands at $116.0 million.
- Akanda AKAN stock increased by 7.27% to $0.23. Akanda's trading volume hit 168.1K shares by close, accounting for 3.0% of its average volume over the last 100 days. The company's market cap stands at $7.8 million.
- VYNE Therapeutics VYNE shares moved upwards by 7.19% to $0.28. The company's market cap stands at $16.1 million.
- Rubius Therapeutics RUBY shares moved upwards by 7.0% to $0.25. The company's market cap stands at $22.2 million.
Losers
- aTyr Pharma LIFE shares decreased by 12.6% to $2.08 during Wednesday's after-market session. The market value of their outstanding shares is at $60.3 million.
- Atara Biotherapeutics ATRA shares fell 8.74% to $4.6. The market value of their outstanding shares is at $436.4 million.
- Azenta AZTA shares decreased by 6.78% to $52.41. The market value of their outstanding shares is at $3.6 billion. As per the news, the Q1 earnings report came out today.
- Athersys ATHX stock declined by 6.05% to $1.71. The company's market cap stands at $29.4 million.
- Cardio Diagnostics Hldgs CDIO stock decreased by 5.69% to $1.99. The company's market cap stands at $18.9 million.
- Gracell Biotechnologies GRCL stock declined by 5.4% to $2.28. The company's market cap stands at $154.3 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in